Navigation Links
DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week

New York, NY (PRWEB) April 18, 2013

The drug safety advocates at are alerting of updated legal news on the site for patients who have taken the diabetes drug Actos. A jury could begin deliberations today in a trial accusing Takeda Pharmaceuticals of causing bladder cancer with their diabetes drug Actos***.

DrugRisks is designed to improve the safety of those taking popular prescription drugs like Actos by providing the latest warnings, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice.

The FDA and European Medicines Agency* have warned that taking Actos for longer than one year may be associated with an increased risk of bladder cancer. Regulators in France and Germany have even banned its use**.

DrugRisks has learned as many as 3,000 patients in the U.S. have filed an Actos lawsuit against Takeda Pharmaceuticals over allegations their drug caused bladder cancer***. The first trial is underway for Jack Cooper, a grandfather who is now terminally ill from the disease***.

Now, the resource center has added legal news showing lawyers are finishing their closing arguments and the jury could begin deliberations as soon as Tuesday or Wednesday this week. A decision is expected soon***.

Lawyers continue to help those diagnosed with bladder cancer after taking Actos file claims. Anyone affected is urged to contact the DrugRisks Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of drug injury litigation against large pharmaceutical companies, DrugRisks only recommends lawyers and law firms who have already handled Actos lawsuits.

Visit today for more information on Actos bladder cancer research, side effects and litigation news, or to speak with a lawyer.

*; an_pha_detail_000033.jsp&mid=WC0b01ac058001d126

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
2. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
3. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
4. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
5. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
6. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
7. Nia Vardalos Speaks Out on Adoption, Bolsters Legal Support for Abused Children
8. Tariq Drabu Supports Latest Campaign Against Illegal Tooth Whitening
9. Best Injury Lawyers? Time Magazine Includes Among Nations Legal Leaders
10. Gun retailers take a hard line on illegal firearm sales, UC Davis survey finds
11. Yasmin Blood-Clotting Lawsuits Update: Resource4thePeople Providing Legal Assistance as Concerns Rise Over Health Risks
Post Your Comments:
(Date:11/25/2015)... ... , ... Many people know of the common symptoms of low thyroid hormone ... But many people who find their cholesterol levels and weight are creeping up are ... if they don’t have any of the other symptoms. , Thyroid hormone plays a ...
(Date:11/25/2015)... ... November 25, 2015 , ... Students and parents have something to be thankful ... Create Real Impact awards. California Casualty is proud to support the contest ... distracted and reckless driving, the number one killer of young drivers. , Almost ...
(Date:11/24/2015)... ... November 24, 2015 , ... Eric C. Seidel, DMD and ... of the revolutionary BIOLASE WaterLase iPlus 2.0™ system. This advanced laser technology uses ... a dentist in Gettysburg, PA . From routine visits to cosmetic treatments, ...
(Date:11/24/2015)... Tucson, AZ (PRWEB) , ... November 24, 2015 , ... ... iPlus 2.0™ treatments from Dr. Angela Wolfman and Dr. Kedar S. Lele, who are ... used for frenectomies, cavities and fillings, the WaterLase iPlus 2.0™ system causes minimal discomfort ...
(Date:11/24/2015)... ... 2015 , ... In an article published November 12th by Obesity ... are or are not eligible for bariatric surgery. The article explains that candidates for ... than 100 pounds overweight, or have a BMI of 35 and over with at ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Developmental, commercial, and regulatory/legal strategies ... of pharmaceutical products, says GBI Research ... strategies all play a key role in boosting the ... . --> Developmental, commercial, ... boosting the profitability of pharmaceutical products, says GBI ...
(Date:11/25/2015)... 2015 ... the  "Global Drug Device Combination Products ... offering.  --> ) ... "Global Drug Device Combination Products Market ... --> Research and Markets ( ...
(Date:11/24/2015)... , Nov. 24, 2015  Natera, ... in non-invasive genetic testing and the analysis ... it will present at the 27 th ... December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, Ph.D., ... financial results, business activities and financial outlook. ...
Breaking Medicine Technology: